WO2018123434A1 - Article absorbant - Google Patents
Article absorbant Download PDFInfo
- Publication number
- WO2018123434A1 WO2018123434A1 PCT/JP2017/043178 JP2017043178W WO2018123434A1 WO 2018123434 A1 WO2018123434 A1 WO 2018123434A1 JP 2017043178 W JP2017043178 W JP 2017043178W WO 2018123434 A1 WO2018123434 A1 WO 2018123434A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- absorbent article
- basis weight
- absorbent
- absorbent core
- article according
- Prior art date
Links
- 230000002745 absorbent Effects 0.000 title claims abstract description 277
- 239000002250 absorbent Substances 0.000 title claims abstract description 277
- 239000003205 fragrance Substances 0.000 claims abstract description 124
- 229920000247 superabsorbent polymer Polymers 0.000 claims abstract description 38
- 239000006096 absorbing agent Substances 0.000 claims abstract description 12
- 210000002700 urine Anatomy 0.000 claims description 61
- IWDCLRJOBJJRNH-UHFFFAOYSA-N p-cresol Chemical compound CC1=CC=C(O)C=C1 IWDCLRJOBJJRNH-UHFFFAOYSA-N 0.000 claims description 43
- 108050002069 Olfactory receptors Proteins 0.000 claims description 40
- 102000012547 Olfactory receptors Human genes 0.000 claims description 39
- 229920000642 polymer Polymers 0.000 claims description 26
- 239000000126 substance Substances 0.000 claims description 26
- 101000982218 Homo sapiens Olfactory receptor 9Q2 Proteins 0.000 claims description 22
- 102100026648 Olfactory receptor 9Q2 Human genes 0.000 claims description 22
- 239000003242 anti bacterial agent Substances 0.000 claims description 20
- 239000000796 flavoring agent Substances 0.000 claims description 18
- 235000019634 flavors Nutrition 0.000 claims description 18
- FZJUFJKVIYFBSY-UHFFFAOYSA-N bourgeonal Chemical compound CC(C)(C)C1=CC=C(CCC=O)C=C1 FZJUFJKVIYFBSY-UHFFFAOYSA-N 0.000 claims description 17
- 238000000034 method Methods 0.000 claims description 15
- 239000000853 adhesive Substances 0.000 claims description 14
- 230000001070 adhesive effect Effects 0.000 claims description 14
- 101001137086 Homo sapiens Olfactory receptor 2W1 Proteins 0.000 claims description 13
- 102100035554 Olfactory receptor 2W1 Human genes 0.000 claims description 13
- YOMSJEATGXXYPX-UHFFFAOYSA-N 2-methoxy-4-vinylphenol Chemical compound COC1=CC(C=C)=CC=C1O YOMSJEATGXXYPX-UHFFFAOYSA-N 0.000 claims description 12
- 101000992266 Homo sapiens Olfactory receptor 5P3 Proteins 0.000 claims description 11
- 102100031850 Olfactory receptor 5P3 Human genes 0.000 claims description 11
- 230000004913 activation Effects 0.000 claims description 11
- 101000594414 Homo sapiens Olfactory receptor 10G4 Proteins 0.000 claims description 9
- 101000594418 Homo sapiens Olfactory receptor 10G7 Proteins 0.000 claims description 9
- 102100035598 Olfactory receptor 10G4 Human genes 0.000 claims description 9
- 102100035612 Olfactory receptor 10G7 Human genes 0.000 claims description 9
- 238000004519 manufacturing process Methods 0.000 claims description 9
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 claims description 8
- 101000586045 Homo sapiens Olfactory receptor 1A1 Proteins 0.000 claims description 7
- 101000614009 Homo sapiens Olfactory receptor 4S2 Proteins 0.000 claims description 7
- 101000586069 Homo sapiens Olfactory receptor 5K1 Proteins 0.000 claims description 7
- 101001137112 Homo sapiens Olfactory receptor 8H1 Proteins 0.000 claims description 7
- 102100030043 Olfactory receptor 1A1 Human genes 0.000 claims description 7
- 102100040567 Olfactory receptor 4S2 Human genes 0.000 claims description 7
- 102100030046 Olfactory receptor 5K1 Human genes 0.000 claims description 7
- 102100035643 Olfactory receptor 8H1 Human genes 0.000 claims description 7
- 239000002304 perfume Substances 0.000 claims description 7
- ISAOCJYIOMOJEB-UHFFFAOYSA-N benzoin Chemical compound C=1C=CC=CC=1C(O)C(=O)C1=CC=CC=C1 ISAOCJYIOMOJEB-UHFFFAOYSA-N 0.000 claims description 6
- 239000011358 absorbing material Substances 0.000 claims description 5
- 239000002657 fibrous material Substances 0.000 claims description 4
- 239000004615 ingredient Substances 0.000 claims description 4
- 230000008569 process Effects 0.000 claims description 4
- NFAVNWJJYQAGNB-UHFFFAOYSA-N 2-methylundecanal Chemical compound CCCCCCCCCC(C)C=O NFAVNWJJYQAGNB-UHFFFAOYSA-N 0.000 claims description 3
- 244000028419 Styrax benzoin Species 0.000 claims description 3
- 235000000126 Styrax benzoin Nutrition 0.000 claims description 3
- 235000008411 Sumatra benzointree Nutrition 0.000 claims description 3
- 239000005844 Thymol Substances 0.000 claims description 3
- 229960002130 benzoin Drugs 0.000 claims description 3
- 235000019382 gum benzoic Nutrition 0.000 claims description 3
- 229960000790 thymol Drugs 0.000 claims description 3
- FQTLCLSUCSAZDY-UHFFFAOYSA-N (+) E(S) nerolidol Natural products CC(C)=CCCC(C)=CCCC(C)(O)C=C FQTLCLSUCSAZDY-UHFFFAOYSA-N 0.000 claims description 2
- FQTLCLSUCSAZDY-ATGUSINASA-N Nerolidol Chemical compound CC(C)=CCC\C(C)=C\CC[C@](C)(O)C=C FQTLCLSUCSAZDY-ATGUSINASA-N 0.000 claims description 2
- WASNIKZYIWZQIP-AWEZNQCLSA-N nerolidol Natural products CC(=CCCC(=CCC[C@@H](O)C=C)C)C WASNIKZYIWZQIP-AWEZNQCLSA-N 0.000 claims description 2
- 230000000994 depressogenic effect Effects 0.000 claims 1
- 239000004599 antimicrobial Substances 0.000 abstract 1
- 235000019645 odor Nutrition 0.000 description 96
- 230000004044 response Effects 0.000 description 29
- 238000012360 testing method Methods 0.000 description 27
- 239000005557 antagonist Substances 0.000 description 26
- 230000000694 effects Effects 0.000 description 17
- 102000005962 receptors Human genes 0.000 description 14
- 108020003175 receptors Proteins 0.000 description 14
- 230000001629 suppression Effects 0.000 description 14
- 239000011248 coating agent Substances 0.000 description 13
- 238000000576 coating method Methods 0.000 description 13
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 9
- 239000000203 mixture Substances 0.000 description 9
- 239000000243 solution Substances 0.000 description 9
- 230000000638 stimulation Effects 0.000 description 9
- 238000011156 evaluation Methods 0.000 description 8
- 238000003825 pressing Methods 0.000 description 8
- 238000010521 absorption reaction Methods 0.000 description 7
- 230000000844 anti-bacterial effect Effects 0.000 description 7
- 238000003670 luciferase enzyme activity assay Methods 0.000 description 7
- 239000000463 material Substances 0.000 description 7
- 239000005871 repellent Substances 0.000 description 7
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- 230000003042 antagnostic effect Effects 0.000 description 6
- 210000001124 body fluid Anatomy 0.000 description 6
- 239000010839 body fluid Substances 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 6
- 239000010419 fine particle Substances 0.000 description 6
- 239000010410 layer Substances 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 239000004820 Pressure-sensitive adhesive Substances 0.000 description 5
- 230000008485 antagonism Effects 0.000 description 5
- 238000004049 embossing Methods 0.000 description 5
- 238000004020 luminiscence type Methods 0.000 description 5
- BTSZTGGZJQFALU-UHFFFAOYSA-N piroctone olamine Chemical compound NCCO.CC(C)(C)CC(C)CC1=CC(C)=CC(=O)N1O BTSZTGGZJQFALU-UHFFFAOYSA-N 0.000 description 5
- 239000000523 sample Substances 0.000 description 5
- 230000001953 sensory effect Effects 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 240000001624 Espostoa lanata Species 0.000 description 4
- 235000009161 Espostoa lanata Nutrition 0.000 description 4
- GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical compound CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 206010021639 Incontinence Diseases 0.000 description 4
- 230000000873 masking effect Effects 0.000 description 4
- 239000002480 mineral oil Substances 0.000 description 4
- 235000010446 mineral oil Nutrition 0.000 description 4
- 239000000377 silicon dioxide Substances 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- 108090000331 Firefly luciferases Proteins 0.000 description 3
- 102000053187 Glucuronidase Human genes 0.000 description 3
- 108010060309 Glucuronidase Proteins 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000012943 hotmelt Substances 0.000 description 3
- 230000002209 hydrophobic effect Effects 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 230000003834 intracellular effect Effects 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 229940081510 piroctone olamine Drugs 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- GRWFGVWFFZKLTI-IUCAKERBSA-N (-)-α-pinene Chemical compound CC1=CC[C@@H]2C(C)(C)[C@H]1C2 GRWFGVWFFZKLTI-IUCAKERBSA-N 0.000 description 2
- WRMNZCZEMHIOCP-UHFFFAOYSA-N 2-phenylethanol Chemical compound OCCC1=CC=CC=C1 WRMNZCZEMHIOCP-UHFFFAOYSA-N 0.000 description 2
- UYWQUFXKFGHYNT-UHFFFAOYSA-N Benzylformate Chemical compound O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- 239000004831 Hot glue Substances 0.000 description 2
- 235000010254 Jasminum officinale Nutrition 0.000 description 2
- 240000005385 Jasminum sambac Species 0.000 description 2
- 244000178870 Lavandula angustifolia Species 0.000 description 2
- 235000010663 Lavandula angustifolia Nutrition 0.000 description 2
- 108060001084 Luciferase Proteins 0.000 description 2
- 108010052090 Renilla Luciferases Proteins 0.000 description 2
- 241000220317 Rosa Species 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- IGODOXYLBBXFDW-UHFFFAOYSA-N alpha-Terpinyl acetate Chemical compound CC(=O)OC(C)(C)C1CCC(C)=CC1 IGODOXYLBBXFDW-UHFFFAOYSA-N 0.000 description 2
- RDOXTESZEPMUJZ-UHFFFAOYSA-N anisole Chemical compound COC1=CC=CC=C1 RDOXTESZEPMUJZ-UHFFFAOYSA-N 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 2
- QUKGYYKBILRGFE-UHFFFAOYSA-N benzyl acetate Chemical compound CC(=O)OCC1=CC=CC=C1 QUKGYYKBILRGFE-UHFFFAOYSA-N 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- ULDHMXUKGWMISQ-UHFFFAOYSA-N carvone Chemical compound CC(=C)C1CC=C(C)C(=O)C1 ULDHMXUKGWMISQ-UHFFFAOYSA-N 0.000 description 2
- NEHNMFOYXAPHSD-UHFFFAOYSA-N citronellal Chemical compound O=CCC(C)CCC=C(C)C NEHNMFOYXAPHSD-UHFFFAOYSA-N 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- KSMVZQYAVGTKIV-UHFFFAOYSA-N decanal Chemical compound CCCCCCCCCC=O KSMVZQYAVGTKIV-UHFFFAOYSA-N 0.000 description 2
- 238000004332 deodorization Methods 0.000 description 2
- 230000001877 deodorizing effect Effects 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- WTEVQBCEXWBHNA-JXMROGBWSA-N geranial Chemical compound CC(C)=CCC\C(C)=C\C=O WTEVQBCEXWBHNA-JXMROGBWSA-N 0.000 description 2
- HIGQPQRQIQDZMP-UHFFFAOYSA-N geranil acetate Natural products CC(C)=CCCC(C)=CCOC(C)=O HIGQPQRQIQDZMP-UHFFFAOYSA-N 0.000 description 2
- HIGQPQRQIQDZMP-DHZHZOJOSA-N geranyl acetate Chemical compound CC(C)=CCC\C(C)=C\COC(C)=O HIGQPQRQIQDZMP-DHZHZOJOSA-N 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 239000001102 lavandula vera Substances 0.000 description 2
- CZVXBFUKBZRMKR-UHFFFAOYSA-N lavandulol Chemical compound CC(C)=CCC(CO)C(C)=C CZVXBFUKBZRMKR-UHFFFAOYSA-N 0.000 description 2
- 235000018219 lavender Nutrition 0.000 description 2
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 2
- UWKAYLJWKGQEPM-LBPRGKRZSA-N linalyl acetate Chemical compound CC(C)=CCC[C@](C)(C=C)OC(C)=O UWKAYLJWKGQEPM-LBPRGKRZSA-N 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- KVWWIYGFBYDJQC-UHFFFAOYSA-N methyl dihydrojasmonate Chemical compound CCCCCC1C(CC(=O)OC)CCC1=O KVWWIYGFBYDJQC-UHFFFAOYSA-N 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- GJQIMXVRFNLMTB-UHFFFAOYSA-N nonyl acetate Chemical compound CCCCCCCCCOC(C)=O GJQIMXVRFNLMTB-UHFFFAOYSA-N 0.000 description 2
- -1 polyethylene Polymers 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 239000011550 stock solution Substances 0.000 description 2
- 239000012209 synthetic fiber Substances 0.000 description 2
- 229920002994 synthetic fiber Polymers 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- NPNUFJAVOOONJE-ZIAGYGMSSA-N β-(E)-Caryophyllene Chemical compound C1CC(C)=CCCC(=C)[C@H]2CC(C)(C)[C@@H]21 NPNUFJAVOOONJE-ZIAGYGMSSA-N 0.000 description 2
- PSQYTAPXSHCGMF-BQYQJAHWSA-N β-ionone Chemical compound CC(=O)\C=C\C1=C(C)CCCC1(C)C PSQYTAPXSHCGMF-BQYQJAHWSA-N 0.000 description 2
- SFEOKXHPFMOVRM-UHFFFAOYSA-N (+)-(S)-gamma-ionone Natural products CC(=O)C=CC1C(=C)CCCC1(C)C SFEOKXHPFMOVRM-UHFFFAOYSA-N 0.000 description 1
- WTARULDDTDQWMU-RKDXNWHRSA-N (+)-β-pinene Chemical compound C1[C@H]2C(C)(C)[C@@H]1CCC2=C WTARULDDTDQWMU-RKDXNWHRSA-N 0.000 description 1
- WTARULDDTDQWMU-IUCAKERBSA-N (-)-Nopinene Natural products C1[C@@H]2C(C)(C)[C@H]1CCC2=C WTARULDDTDQWMU-IUCAKERBSA-N 0.000 description 1
- HLCSDJLATUNSSI-JXMROGBWSA-N (2e)-3,7-dimethylocta-2,6-dienenitrile Chemical compound CC(C)=CCC\C(C)=C\C#N HLCSDJLATUNSSI-JXMROGBWSA-N 0.000 description 1
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 1
- KRLBLPBPZSSIGH-CSKARUKUSA-N (6e)-3,7-dimethylnona-1,6-dien-3-ol Chemical compound CC\C(C)=C\CCC(C)(O)C=C KRLBLPBPZSSIGH-CSKARUKUSA-N 0.000 description 1
- CZVXBFUKBZRMKR-JTQLQIEISA-N (R)-lavandulol Natural products CC(C)=CC[C@@H](CO)C(C)=C CZVXBFUKBZRMKR-JTQLQIEISA-N 0.000 description 1
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 1
- WUOACPNHFRMFPN-SECBINFHSA-N (S)-(-)-alpha-terpineol Chemical compound CC1=CC[C@@H](C(C)(C)O)CC1 WUOACPNHFRMFPN-SECBINFHSA-N 0.000 description 1
- RUJPNZNXGCHGID-UHFFFAOYSA-N (Z)-beta-Terpineol Natural products CC(=C)C1CCC(C)(O)CC1 RUJPNZNXGCHGID-UHFFFAOYSA-N 0.000 description 1
- JRJBVWJSTHECJK-LUAWRHEFSA-N (z)-3-methyl-4-(2,6,6-trimethylcyclohex-2-en-1-yl)but-3-en-2-one Chemical compound CC(=O)C(\C)=C/C1C(C)=CCCC1(C)C JRJBVWJSTHECJK-LUAWRHEFSA-N 0.000 description 1
- WEEGYLXZBRQIMU-UHFFFAOYSA-N 1,8-cineole Natural products C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 1
- GQBVHGLNSHPKPG-UHFFFAOYSA-N 1-(2-tert-butylcyclohexyl)oxybutan-2-ol Chemical compound CCC(O)COC1CCCCC1C(C)(C)C GQBVHGLNSHPKPG-UHFFFAOYSA-N 0.000 description 1
- VCOCESNMLNDPLX-UHFFFAOYSA-N 2,2,8,8-tetramethyl-octahydro-1h-2,4a-methanonapthalene-10-one Chemical compound O=C1CCC(C)(C)C2(C3)C1C(C)(C)C3CC2 VCOCESNMLNDPLX-UHFFFAOYSA-N 0.000 description 1
- FLUWAIIVLCVEKF-UHFFFAOYSA-N 2-Methyl-1-phenyl-2-propanyl acetate Chemical compound CC(=O)OC(C)(C)CC1=CC=CC=C1 FLUWAIIVLCVEKF-UHFFFAOYSA-N 0.000 description 1
- HMKKIXGYKWDQSV-SDNWHVSQSA-N 2-Pentyl-3-phenyl-2-propenal Chemical compound CCCCC\C(C=O)=C/C1=CC=CC=C1 HMKKIXGYKWDQSV-SDNWHVSQSA-N 0.000 description 1
- KNHGOYVXAHUDHP-UHFFFAOYSA-N 2-[2-(4-methylcyclohex-3-en-1-yl)propyl]cyclopentan-1-one Chemical compound C1CC(C)=CCC1C(C)CC1CCCC1=O KNHGOYVXAHUDHP-UHFFFAOYSA-N 0.000 description 1
- NEAQRZUHTPSBBM-UHFFFAOYSA-N 2-hydroxy-3,3-dimethyl-7-nitro-4h-isoquinolin-1-one Chemical compound C1=C([N+]([O-])=O)C=C2C(=O)N(O)C(C)(C)CC2=C1 NEAQRZUHTPSBBM-UHFFFAOYSA-N 0.000 description 1
- YSLIPUSJNFIFAB-UHFFFAOYSA-N 2-oxopyridine-1-carboxylic acid Chemical class OC(=O)N1C=CC=CC1=O YSLIPUSJNFIFAB-UHFFFAOYSA-N 0.000 description 1
- BDCFWIDZNLCTMF-UHFFFAOYSA-N 2-phenylpropan-2-ol Chemical compound CC(C)(O)C1=CC=CC=C1 BDCFWIDZNLCTMF-UHFFFAOYSA-N 0.000 description 1
- STABOCQBMNLCRM-UHFFFAOYSA-N 3,7,11-trimethyldodeca-1,6,10-trien-3-ol Chemical compound CC(C)=CCCC(C)=CCCC(C)(O)C=C.CC(C)=CCCC(C)=CCCC(C)(O)C=C STABOCQBMNLCRM-UHFFFAOYSA-N 0.000 description 1
- JRTBBCBDKSRRCY-UHFFFAOYSA-N 3,7-dimethyloct-6-en-3-ol Chemical compound CCC(C)(O)CCC=C(C)C JRTBBCBDKSRRCY-UHFFFAOYSA-N 0.000 description 1
- GOLORTLGFDVFDW-UHFFFAOYSA-N 3-(1h-benzimidazol-2-yl)-7-(diethylamino)chromen-2-one Chemical compound C1=CC=C2NC(C3=CC4=CC=C(C=C4OC3=O)N(CC)CC)=NC2=C1 GOLORTLGFDVFDW-UHFFFAOYSA-N 0.000 description 1
- GTNCESCYZPMXCJ-UHFFFAOYSA-N 3-Phenylpropyl propanoate Chemical compound CCC(=O)OCCCC1=CC=CC=C1 GTNCESCYZPMXCJ-UHFFFAOYSA-N 0.000 description 1
- OXYRENDGHPGWKV-UHFFFAOYSA-N 3-methyl-5-phenylpentan-1-ol Chemical compound OCCC(C)CCC1=CC=CC=C1 OXYRENDGHPGWKV-UHFFFAOYSA-N 0.000 description 1
- WWJLCYHYLZZXBE-UHFFFAOYSA-N 5-chloro-1,3-dihydroindol-2-one Chemical compound ClC1=CC=C2NC(=O)CC2=C1 WWJLCYHYLZZXBE-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 229910002012 Aerosil® Inorganic materials 0.000 description 1
- 229910002016 Aerosil® 200 Inorganic materials 0.000 description 1
- 240000007436 Cananga odorata Species 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 235000012766 Cannabis sativa ssp. sativa var. sativa Nutrition 0.000 description 1
- 235000012765 Cannabis sativa ssp. sativa var. spontanea Nutrition 0.000 description 1
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 1
- WTEVQBCEXWBHNA-UHFFFAOYSA-N Citral Natural products CC(C)=CCCC(C)=CC=O WTEVQBCEXWBHNA-UHFFFAOYSA-N 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- FKUPPRZPSYCDRS-UHFFFAOYSA-N Cyclopentadecanolide Chemical compound O=C1CCCCCCCCCCCCCCO1 FKUPPRZPSYCDRS-UHFFFAOYSA-N 0.000 description 1
- WEEGYLXZBRQIMU-WAAGHKOSSA-N Eucalyptol Chemical compound C1C[C@H]2CC[C@]1(C)OC2(C)C WEEGYLXZBRQIMU-WAAGHKOSSA-N 0.000 description 1
- 241000134874 Geraniales Species 0.000 description 1
- 239000005792 Geraniol Substances 0.000 description 1
- GLZPCOQZEFWAFX-YFHOEESVSA-N Geraniol Natural products CC(C)=CCC\C(C)=C/CO GLZPCOQZEFWAFX-YFHOEESVSA-N 0.000 description 1
- DUKPKQFHJQGTGU-UHFFFAOYSA-N Hexyl salicylic acid Chemical compound CCCCCCOC(=O)C1=CC=CC=C1O DUKPKQFHJQGTGU-UHFFFAOYSA-N 0.000 description 1
- PMGCQNGBLMMXEW-UHFFFAOYSA-N Isoamyl salicylate Chemical compound CC(C)CCOC(=O)C1=CC=CC=C1O PMGCQNGBLMMXEW-UHFFFAOYSA-N 0.000 description 1
- KGEKLUUHTZCSIP-UHFFFAOYSA-N Isobornyl acetate Natural products C1CC2(C)C(OC(=O)C)CC1C2(C)C KGEKLUUHTZCSIP-UHFFFAOYSA-N 0.000 description 1
- BJIOGJUNALELMI-ONEGZZNKSA-N Isoeugenol Natural products COC1=CC(\C=C\C)=CC=C1O BJIOGJUNALELMI-ONEGZZNKSA-N 0.000 description 1
- 239000005089 Luciferase Substances 0.000 description 1
- GLZPCOQZEFWAFX-JXMROGBWSA-N Nerol Natural products CC(C)=CCC\C(C)=C\CO GLZPCOQZEFWAFX-JXMROGBWSA-N 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- WTARULDDTDQWMU-UHFFFAOYSA-N Pseudopinene Natural products C1C2C(C)(C)C1CCC2=C WTARULDDTDQWMU-UHFFFAOYSA-N 0.000 description 1
- 229920001131 Pulp (paper) Polymers 0.000 description 1
- 229920000297 Rayon Polymers 0.000 description 1
- 239000001940 [(1R,4S,6R)-1,7,7-trimethyl-6-bicyclo[2.2.1]heptanyl] acetate Substances 0.000 description 1
- 229940022663 acetate Drugs 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 108060000200 adenylate cyclase Proteins 0.000 description 1
- 102000030621 adenylate cyclase Human genes 0.000 description 1
- XCPQUQHBVVXMRQ-UHFFFAOYSA-N alpha-Fenchene Natural products C1CC2C(=C)CC1C2(C)C XCPQUQHBVVXMRQ-UHFFFAOYSA-N 0.000 description 1
- OVKDFILSBMEKLT-UHFFFAOYSA-N alpha-Terpineol Natural products CC(=C)C1(O)CCC(C)=CC1 OVKDFILSBMEKLT-UHFFFAOYSA-N 0.000 description 1
- MVNCAPSFBDBCGF-UHFFFAOYSA-N alpha-pinene Natural products CC1=CCC23C1CC2C3(C)C MVNCAPSFBDBCGF-UHFFFAOYSA-N 0.000 description 1
- 229940088601 alpha-terpineol Drugs 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 229940027983 antiseptic and disinfectant quaternary ammonium compound Drugs 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 230000002238 attenuated effect Effects 0.000 description 1
- 230000003190 augmentative effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 229960001716 benzalkonium Drugs 0.000 description 1
- CYDRXTMLKJDRQH-UHFFFAOYSA-N benzododecinium Chemical compound CCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1 CYDRXTMLKJDRQH-UHFFFAOYSA-N 0.000 description 1
- 229940007550 benzyl acetate Drugs 0.000 description 1
- NPNUFJAVOOONJE-UHFFFAOYSA-N beta-cariophyllene Natural products C1CC(C)=CCCC(=C)C2CC(C)(C)C21 NPNUFJAVOOONJE-UHFFFAOYSA-N 0.000 description 1
- 229930006722 beta-pinene Natural products 0.000 description 1
- 235000009120 camo Nutrition 0.000 description 1
- NPNUFJAVOOONJE-UONOGXRCSA-N caryophyllene Natural products C1CC(C)=CCCC(=C)[C@@H]2CC(C)(C)[C@@H]21 NPNUFJAVOOONJE-UONOGXRCSA-N 0.000 description 1
- IRAQOCYXUMOFCW-CXTNEJHOSA-N cedrene Chemical compound C1[C@]23[C@H](C)CC[C@H]3C(C)(C)[C@H]1C(C)=CC2 IRAQOCYXUMOFCW-CXTNEJHOSA-N 0.000 description 1
- 235000005607 chanvre indien Nutrition 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229960005233 cineole Drugs 0.000 description 1
- 235000017803 cinnamon Nutrition 0.000 description 1
- BJIOGJUNALELMI-ARJAWSKDSA-N cis-isoeugenol Chemical compound COC1=CC(\C=C/C)=CC=C1O BJIOGJUNALELMI-ARJAWSKDSA-N 0.000 description 1
- 229930003633 citronellal Natural products 0.000 description 1
- 235000000983 citronellal Nutrition 0.000 description 1
- JOZKFWLRHCDGJA-UHFFFAOYSA-N citronellol acetate Chemical compound CC(=O)OCCC(C)CCC=C(C)C JOZKFWLRHCDGJA-UHFFFAOYSA-N 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 230000001149 cognitive effect Effects 0.000 description 1
- 239000013065 commercial product Substances 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 239000013068 control sample Substances 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- BGTOWKSIORTVQH-UHFFFAOYSA-N cyclopentanone Chemical compound O=C1CCCC1 BGTOWKSIORTVQH-UHFFFAOYSA-N 0.000 description 1
- 239000002781 deodorant agent Substances 0.000 description 1
- IRAQOCYXUMOFCW-UHFFFAOYSA-N di-epi-alpha-cedrene Natural products C1C23C(C)CCC3C(C)(C)C1C(C)=CC2 IRAQOCYXUMOFCW-UHFFFAOYSA-N 0.000 description 1
- XSNQECSCDATQEL-UHFFFAOYSA-N dihydromyrcenol Chemical compound C=CC(C)CCCC(C)(C)O XSNQECSCDATQEL-UHFFFAOYSA-N 0.000 description 1
- 229930008394 dihydromyrcenol Natural products 0.000 description 1
- 229940095104 dimethyl benzyl carbinyl acetate Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- LCWMKIHBLJLORW-UHFFFAOYSA-N gamma-carene Natural products C1CC(=C)CC2C(C)(C)C21 LCWMKIHBLJLORW-UHFFFAOYSA-N 0.000 description 1
- 229930007090 gamma-ionone Natural products 0.000 description 1
- 229940113087 geraniol Drugs 0.000 description 1
- 239000011487 hemp Substances 0.000 description 1
- ZUVCYFMOHFTGDM-UHFFFAOYSA-N hexadecyl dihydrogen phosphate Chemical compound CCCCCCCCCCCCCCCCOP(O)(O)=O ZUVCYFMOHFTGDM-UHFFFAOYSA-N 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 239000000017 hydrogel Substances 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 229930007744 linalool Natural products 0.000 description 1
- UWKAYLJWKGQEPM-UHFFFAOYSA-N linalool acetate Natural products CC(C)=CCCC(C)(C=C)OC(C)=O UWKAYLJWKGQEPM-UHFFFAOYSA-N 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 238000003468 luciferase reporter gene assay Methods 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- UZKWTJUDCOPSNM-UHFFFAOYSA-N methoxybenzene Substances CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 description 1
- HRGPYCVTDOECMG-RHBQXOTJSA-N methyl cedryl ether Chemical compound C1[C@@]23[C@H](C)CC[C@H]2C(C)(C)[C@]1([H])[C@@](OC)(C)CC3 HRGPYCVTDOECMG-RHBQXOTJSA-N 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- HIGQPQRQIQDZMP-FLIBITNWSA-N neryl acetate Chemical compound CC(C)=CCC\C(C)=C/COC(C)=O HIGQPQRQIQDZMP-FLIBITNWSA-N 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 239000004745 nonwoven fabric Substances 0.000 description 1
- HFPZCAJZSCWRBC-UHFFFAOYSA-N p-cymene Chemical compound CC(C)C1=CC=C(C)C=C1 HFPZCAJZSCWRBC-UHFFFAOYSA-N 0.000 description 1
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 229940067107 phenylethyl alcohol Drugs 0.000 description 1
- JOHZPMXAZQZXHR-UHFFFAOYSA-N pipemidic acid Chemical compound N1=C2N(CC)C=C(C(O)=O)C(=O)C2=CN=C1N1CCNCC1 JOHZPMXAZQZXHR-UHFFFAOYSA-N 0.000 description 1
- 229960001732 pipemidic acid Drugs 0.000 description 1
- SATCULPHIDQDRE-UHFFFAOYSA-N piperonal Chemical compound O=CC1=CC=C2OCOC2=C1 SATCULPHIDQDRE-UHFFFAOYSA-N 0.000 description 1
- 229950001046 piroctone Drugs 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 239000011164 primary particle Substances 0.000 description 1
- 150000003856 quaternary ammonium compounds Chemical class 0.000 description 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 1
- GRWFGVWFFZKLTI-UHFFFAOYSA-N rac-alpha-Pinene Natural products CC1=CCC2C(C)(C)C1C2 GRWFGVWFFZKLTI-UHFFFAOYSA-N 0.000 description 1
- 239000002964 rayon Substances 0.000 description 1
- 239000002464 receptor antagonist Substances 0.000 description 1
- 229940044551 receptor antagonist Drugs 0.000 description 1
- 239000013074 reference sample Substances 0.000 description 1
- 230000002940 repellent Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 239000004583 superabsorbent polymers (SAPs) Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229920003002 synthetic resin Polymers 0.000 description 1
- 239000000057 synthetic resin Substances 0.000 description 1
- QJVXKWHHAMZTBY-GCPOEHJPSA-N syringin Chemical compound COC1=CC(\C=C\CO)=CC(OC)=C1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 QJVXKWHHAMZTBY-GCPOEHJPSA-N 0.000 description 1
- BJIOGJUNALELMI-UHFFFAOYSA-N trans-isoeugenol Natural products COC1=CC(C=CC)=CC=C1O BJIOGJUNALELMI-UHFFFAOYSA-N 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- SFEOKXHPFMOVRM-BQYQJAHWSA-N γ-ionone Chemical compound CC(=O)\C=C\C1C(=C)CCCC1(C)C SFEOKXHPFMOVRM-BQYQJAHWSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/15—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/15—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
- A61F13/53—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators characterised by the absorbing medium
Definitions
- the present invention relates to an absorbent article.
- the absorbent article may be perfumed to mask the odor in order to prevent the odor generated from the absorbed excrement from being perceived. Often done.
- the fragrance is generally applied to the absorbent body in the absorbent article.
- excrement such as urine absorbed by the absorbent body is mixed with the fragrance, another odor is generated, and the masking effect by the fragrance may be reduced.
- Patent Document 1 discloses an antibacterial agent of a quaternary ammonium salt between an absorbent layer and a surface sheet.
- An absorbent article having a functional material region in which a functional material containing a fragrance and a fragrance is disposed has been proposed.
- the body fluid discharged from the wearer touched the antibacterial agent in the process of being guided from the surface sheet side to the absorption layer side, and the body fluid once absorbed by the absorption layer leaked to the surface sheet side Even in this case, since the body fluid touches the antibacterial agent, the literature discloses that the antibacterial function can be exhibited not only at the time of absorption when the body fluid is absorbed but also after absorption of the body fluid.
- the present invention provides an absorbent article having a top sheet, a back sheet, and an absorbent body disposed between both sheets.
- the said absorber is equipped with an absorptive core and the coating sheet which coat
- the absorbent core contains a superabsorbent polymer.
- the superabsorbent polymer contains an antibacterial agent.
- the covering sheet contains a fragrance.
- FIG. 1 is thickness direction sectional drawing when cut along the width direction in the center area along a longitudinal direction which shows one Embodiment of the absorbent article of this invention.
- FIG. 2 is a perspective view of the absorbent core in the absorbent body of the absorbent article shown in FIG. 1 with its non-skin facing surface facing upward.
- FIG. 3 is a cross-sectional view in the thickness direction along the width direction in the central region along the longitudinal direction of the absorbent core in the absorbent body of the absorbent article shown in FIG. 1.
- FIG. 4 (a) is a schematic diagram showing the mechanism by which the target odor molecule activates the olfactory receptor
- FIG. 4 (b) shows the receptor of the target odor molecule by olfactory receptor antagonism.
- FIG. 5 shows the results of a luciferase assay that measures the response of olfactory receptors to p-cresol.
- FIG. 7 shows the results of a luciferase assay in which the response of an olfactory receptor to 2-methoxy-4-vinylphenol was measured.
- FIG. 9 is an analysis result of a luciferase assay that measures the inhibitory effect of the response of the olfactory receptor OR9Q2 by Nectaryl and Bourgeonal.
- FIG. 10 shows the results of a sensory test in which the effect of suppressing urine odor by an OR9Q2 antagonist was measured.
- the present invention relates to an improvement of a perfumed absorbent article, and more particularly relates to an absorbent article capable of effectively suppressing odor caused by absorption of excrement.
- the absorbent article 1 shown in FIG. 1 includes a top sheet 2 disposed on the skin facing surface side, a back sheet 3 disposed on the non-skin facing surface side, and an absorbent body 4 interposed between both sheets 2 and 3. It has a long shape in one direction having a longitudinal direction and a width direction.
- the absorbent article 1 includes a three-dimensional gather 5 including a water-repellent sheet 6 and an elastic member 61 fixed to the water-repellent sheet 6 on both sides in the longitudinal direction.
- the solid gather 5 stands up toward the wearer when worn.
- the longitudinal direction of the absorbent article means a direction that coincides with the wearer's front-rear direction when worn.
- Reference to the width direction of the absorbent article means a direction substantially orthogonal to the longitudinal direction.
- the direction indicated by the symbol Y (Y direction) is the width direction of the absorbent article (absorber, absorbent core, three-dimensional gather).
- the thickness direction of an absorbent article is a direction shown by Z in FIG.
- the skin facing surface is a surface directed to the skin side of the wearer when the absorbent article is worn in the absorbent article, and the non-skin facing surface is the skin side when the absorbent article is worn in the absorbent article. Is the surface facing the opposite side (usually the clothing side).
- the top sheet 2 in the absorbent article 1 is liquid permeable.
- One side of the top sheet 2 constitutes the skin facing surface of the absorbent article 1.
- the back sheet 3 has liquid impermeability or liquid impermeability.
- One surface of the back sheet 3 constitutes a surface on the non-skin facing surface side of the absorbent article 1 directed to the clothing side.
- the top sheet 2, the back sheet 3, and the absorbent body 4 each have a shape that is long in the same direction as the longitudinal direction of the absorbent article 1.
- the pressure-sensitive adhesive layer 10 may be provided on the surface (non-skin facing surface) on the back sheet 3 side of the absorbent article 1 according to the specific application of the absorbent article 1.
- the pressure-sensitive adhesive layer 10 is used to fix the absorbent article 1 to underwear or another absorbent article when the absorbent article 1 is worn.
- the absorber 4 is sandwiched and fixed between the top sheet 2 and the back sheet 3. Both side portions along the longitudinal direction of the top sheet 2 are wound down to the non-skin facing surface side of the absorbent body 4 and are joined to the absorbent body 4 and / or the back sheet 3 between the absorbent body 4 and the back sheet 3. ing.
- the absorbent body 4 is configured by covering the absorbent core 40 with a liquid-permeable covering sheet 44 made of tissue paper or a water-permeable nonwoven fabric.
- the covering sheet 44 preferably covers the entire skin facing surface of the absorbent core 40.
- the coating sheet 44 also covers the entire area of the non-skin facing surface of the absorbent core 40.
- the covering sheet 44 also covers the entire area of the left and right side surfaces of the absorbent core 40. In the embodiment shown in FIG. 1, one covering sheet 44 is used, and the covering sheet 44 covers the skin facing surface, the non-skin facing surface, and both side surfaces of the absorbent core 40.
- the covering sheet 44 covers the absorbent core 40 so that the left and right side edge regions overlap each other to form an overlapping portion 44A.
- the overlapping portion 44 ⁇ / b> A is formed on the non-skin facing surface of the absorbent core 40.
- the absorbent body 4 has a space 46 defined between the side surface 40S of the absorbent core 40 and the covering sheet 44 so as to be separated from each other.
- This space 46 exists in the state before wearing of the absorbent article 1, and preferably also exists in the wearing state of the absorbent article 1.
- the distance between the side surface 40S of the absorbent core 40 and the covering sheet 44 is preferably 1 mm or more, more preferably 2 mm or more, and 3 mm or more. More preferably it is. Further, it is preferably 10 mm or less, more preferably 7 mm or less, and even more preferably 5 mm or less.
- the distance between the side surface 40S of the absorbent core 40 and the covering sheet 44 is preferably 1 mm or more and 10 mm or less, and preferably 2 mm or more and 7 mm or less. More preferably, it is more preferably 3 mm or more and 5 mm or less.
- An adhesive such as a hot-melt pressure-sensitive adhesive is applied between the covering sheet 44 and the surface sheet 2 of the absorbent body 4 in a pattern such as dots, spirals or stripes. Are joined together.
- an adhesive (not shown) is applied between the cover sheet 44 and the back sheet 3 in the absorbent body 4, thereby bonding them together.
- the absorbent article 1 includes a pair of three-dimensional gathers 5 and 5 that stand on the wearer side on both sides along the longitudinal direction.
- the three-dimensional gathers 5 are arranged on both sides of the absorbent body 4 covered with the top sheet 2.
- a pair of water-repellent sheets 6 and 6 for forming a three-dimensional gather having a constant width is disposed on each of both side portions along the longitudinal direction of the absorbent article 1 over substantially the entire length in the longitudinal direction. Yes.
- Each water-repellent sheet 6 is folded in two so that a bent portion extending along the longitudinal direction is formed.
- the water-repellent sheet 6 folded in two has two side edges extending along the longitudinal direction thereof, disposed on the back side of the absorbent body 4 together with the top sheet 2, and joined to the back sheet 3 together with the top sheet 2. Thereby, the fixed end portion 53 of the three-dimensional gather 5 is formed.
- the free end 62 of the three-dimensional gather 5 is composed of a bent portion of the water-repellent sheet 6 folded in half. The free end 62 side of the three-dimensional gather 5 is folded back toward the outside in the width direction Y along the longitudinal direction.
- the free end part 62 of the three-dimensional gather 5 sees the outer side of the width direction Y, ie, the side edge 1a side of the absorbent article 1, seeing from the centerline (not shown) extended in the longitudinal direction of the absorbent article 1. Come to face.
- one or a plurality of elastic members 61 are arranged to extend in the longitudinal direction.
- the elastic member 61 is fixed to the water repellent sheet 6 in an extended state.
- the elastic member 61 is provided over substantially the entire length of the three-dimensional gather 5 in the longitudinal direction.
- the absorbent article 1 has a pressing groove 7 formed in the center region in the longitudinal direction with the surface facing the skin being recessed.
- the compressed grooves 7 extend in the longitudinal direction of the absorbent article 1, and are arranged one by one on both sides of a center line (not shown) that bisects the absorbent article 1 into left and right.
- Each pressing groove 7 extends along the longitudinal direction of the absorbent article 1.
- the compressed groove 7 In the expression of extending along the longitudinal direction, in addition to the case where the compressed groove 7 extends linearly, the compressed groove 7 has an arc shape or other shape, but generally extends in the longitudinal direction. It is also included.
- the pressing grooves 7 and 7 have a symmetrical shape with respect to the center line.
- the pressing groove 7 can be formed, for example, in a gentle curved shape (arc shape) that is convex from the outside in the width direction Y toward the center line side. In this case, it is preferable that the position where the compressed grooves 7 and 7 are closest to each other is a central position or a position in the vicinity thereof among positions along the longitudinal direction of the absorbent article 1.
- the pressing grooves 7 and 7 can be formed according to a conventional method by embossing such as embossing with or without heat, or ultrasonic embossing.
- embossing such as embossing with or without heat, or ultrasonic embossing.
- a predetermined portion is pushed in a concave shape from the topsheet 2 side to the absorbent body 4 side by embossing (squeezing)
- the compressed groove 7 can be formed in the predetermined portion.
- both the topsheet 2 and the absorbent body 4 are recessed in the compressed groove 7.
- the top sheet 2 and the absorber 4 are integrated by pressing and an adhesive.
- the pressing groove 7 includes a large number of deep depressions (relatively deep depressions, high embossing parts) such as rectangles, squares, rhombuses, circles, and crosses in plan view, and shallow depressions (relatively shallow depressions). Or a low embossed portion) may be alternately connected to form a continuous line as a whole, or a large number of depressions may be intermittently arranged.
- FIG. 2 shows a perspective view of the absorbent core 40 in the absorbent body 4 of the absorbent article 1 shown in FIG.
- the absorbent core 40 shown in the figure is turned upside down and its non-skin facing surface is directed to the upper surface.
- FIG. 3 shows a cross-sectional view of the absorbent core 40 in the width direction.
- the absorbent core 40 has a first surface 40A and a second surface 40B.
- 40A of 1st surfaces are skin opposing surfaces, and have faced the surface sheet 2 or the intermediate sheet (not shown) side used as needed.
- the second surface 40B is the non-skin facing surface side and faces the back sheet 3 side.
- the absorbent core 40 is adjacent to the high basis weight portion 41 and the high basis weight portion 41 having a relatively high basis weight and a convex shape protruding toward the back sheet 3 side. And a low basis weight portion 42 having a relatively low basis weight and recessed from the back sheet 3 side toward the top sheet 2 side.
- the high basis weight portion 41 and the low basis weight portion 42 are integrally formed.
- the absorbent core 40 has an uneven structure on the non-skin facing surface side, and the skin facing surface side is a flat surface. When the non-skin facing surface side of the absorbent core 40 has an uneven structure, the absorbent core 40 is easily deformed flexibly by an external force applied from the width direction of the absorbent core 40.
- “Integrally molded” means that these parts are integrated without being separated from each other without using a bonding means such as an adhesive or heat fusion, and are integrally formed from the same material. Means that When these parts are integrally molded, the body fluid has continuity that can move smoothly.
- a manufacturing method of the absorbent core 40 having such a structure is described in, for example, Japanese Patent Application Laid-Open No. 2013-255567.
- the absorbent core 40 is made of a liquid absorbing material.
- the liquid-absorbing material the same materials as those conventionally used in the technical field of absorbent articles can be used.
- various fiber materials as the liquid-absorbing material specifically, natural fibers such as wood pulp, cotton and hemp; synthetic fibers made of synthetic resins such as polyethylene and polypropylene; semi-synthetic fibers such as acetate and rayon, etc. Can do. These fiber materials can be used singly or in combination of two or more.
- the absorbent core 40 contains a superabsorbent polymer made of a hydrogel material that has the property of absorbing water and swelling and retaining water. In particular, as shown in FIG.
- a layer of a single pulp is formed on the most non-skin facing surface side, that is, the surface of the tip of the high basis weight portion 41 is composed only of pulp, and is a highly absorbent polymer. It is preferable to have a polymer non-existing region 43 that is absent. It is preferable to have the polymer non-existing region 43 on the tip surface of the high basis weight portion 41 because the hardness due to the superabsorbent polymer can be reduced on the non-skin facing surface of the diaper 10.
- the polymer non-existing region 43 is preferably present on the entire convex surface of the high basis weight portion 41 and the tip surface of the low basis weight portion 42, that is, the entire surface of the uneven structure of the non-skin facing surface.
- the skin-facing surface which is a flat surface in the absorbent core 40
- the skin-facing surface also has a polymer non-existing region 45 that is made of only pulp and in which no superabsorbent polymer is present.
- both side surfaces of the absorbent core 40 have a polymer non-existing region which is composed of only pulp and in which no superabsorbent polymer is present.
- the absorbent core 40 preferably has a polymer non-existing region over the entire surface thereof.
- the thickness of the polymer non-existing region is preferably 0.1 mm or more and 1 mm or less inward from the surface.
- the thickness of the polymer non-existing region in the convex portion of the absorbent core 40 is preferably 0.1 mm or more, more preferably 0.3 mm or more, and preferably 2 mm or less, more preferably 1 mm or less.
- a manufacturing method of the absorbent core 40 having such a structure is described in, for example, Japanese Patent Application Laid-Open No. 2013-255567.
- a plurality of low basis weight portions 42 extend in parallel to the longitudinal direction X of the absorbent core 40.
- the low basis weight portion 42 has a plurality of the low basis weight portions 42 extending in parallel with the width direction Y of the absorbent core 40.
- the low basis weight portion 42 has an orthogonal lattice shape extending in the longitudinal direction and the width direction of the absorbent core 40.
- the high basic weight part 41 is located in the lattice formed by the low basic weight part 42. Therefore, each high basic weight part 41 is divided by the low basic weight part 42, and is independent independently.
- the shapes of the respective high basis weight portions 41 are substantially the same, are rectangular in plan view, and the length in the longitudinal direction X is larger than the length in the width direction Y.
- the low basic weight part 42 extends in the longitudinal direction X and the width direction Y of the absorbent core 40 and is connected to each other to form a continuous body.
- the width of the low basis weight portion 42 extending in the longitudinal direction X of the absorbent core 40 and the width of the low basis weight portion 42 extending in the width direction Y of the absorbent core 40 may be the same or different. Good.
- the absorbent core 40 has a block structure including a plurality of high basis weight portions 41 having a relatively high basis weight and low basis weight portions 42 having a relatively low basis weight, and The periphery of each high basis weight portion 41 is surrounded by the low basis weight portion 42 over the entire area to form an independent block structure. Further, the outermost periphery of the block structure is surrounded by the low basis weight portion 42. The corners of the low basis weight portion 42 located at the outermost periphery of the block structure are preferably rounded to draw a convex curve toward the outside.
- the block structure including the high basis weight portion 41 and the low basis weight portion 42 is formed over the entire area in the longitudinal direction X and the entire width direction Y of the absorbent core 40.
- the absorbent core 40 becomes flexible in both the longitudinal direction X and the width direction Y, and is absorbed due to that.
- the sex core 40 tends to follow the shape of the wearer's body. Furthermore, the excreted liquid flows while being guided by the low-thickness portion having a small thickness, so that the diffusibility in the longitudinal direction and the width direction of the absorbent core 40 can be improved.
- the lower limit of the basis weight of the low basis weight portion 42 relative to the basis weight of the high basis weight portion 41 is preferably 20% or more, and more preferably 30% or more.
- the upper limit is preferably 80% or less, and more preferably 70% or less.
- the lower limit of the basis weight of the high basis weight portion 41 itself is preferably 300 g / m 2 or more, and more preferably 350 g / m 2 or more.
- the upper limit is preferably 900 g / m 2 or less, more preferably 800 g / m 2 or less.
- the lower limit of the basic weight is preferably 100 g / m 2 or more, and more preferably 150 g / m 2 or more.
- the upper limit is preferably 500 g / m 2 or less, more preferably 400 g / m 2 or less.
- the basis weight is measured according to the method described in paragraph [0027] of JP2013-255567A.
- the high basis weight part 41 not only has a larger basis weight than the low basis weight part 42 but also has a larger thickness.
- the lower limit of the thickness of the low basis weight portion 42 relative to the thickness of the high basis weight portion 41 is preferably 30% or more, and more preferably 40% or more.
- the upper limit is preferably 90% or less, and more preferably 80% or less.
- the lower limit of the thickness of the high basis weight portion 41 itself is preferably 2 mm or more, and more preferably 3 mm or more.
- the upper limit is preferably 8 mm or less, more preferably 7 mm or less.
- the lower limit of the thickness is preferably 1.5 mm or more, and more preferably 2.5 mm or more.
- the upper limit is preferably 4.5 mm or less, and more preferably 4 mm or less.
- the thicknesses of the high basis weight portion 41 and the low basis weight portion 42 are measured according to the method described in paragraph [0028] of JP2013-255567A.
- the concavo-convex structure which consists of the recessed parts 52X and 52Y which consist of the low basic weight parts 42 is formed.
- the edge part of the recessed part 52X extended in the longitudinal direction X of the absorbent core 40 has reached the edge 40Y in the longitudinal direction X of the absorbent core 40.
- the end of the recess 52 ⁇ / b> Y extending in the width direction Y reaches the side edge 40 ⁇ / b> X in the width direction Y of the absorbent core 40.
- the superabsorbent polymer contained in the absorbent core 40 preferably contains an antibacterial agent. That is, it is preferable to impart an antibacterial action to the superabsorbent polymer. Since the superabsorbent polymer has an antibacterial action, when the superabsorbent polymer absorbs and retains excrement such as urine, the excrement is less likely to rot, so that it is possible to suppress the generation of odor. Is played.
- the presence of the polymer non-existing regions 43 and 45 on the surface of the absorbent core 40 that is, the presence of the superabsorbent polymer inside the absorbent core 40, thereby the superabsorbent polymer. Can further suppress the generation of odor from the excrement held by the.
- the antibacterial agent used in the present invention is not particularly limited, but a hydrophobic antibacterial agent is preferably used from the viewpoint of imparting a long-lasting and continuous antibacterial action to the superabsorbent polymer.
- hydrophobic antibacterial agents include hydroxamic acid derivatives such as piroctone olamine (also known as piroctone ethanolamine), pyridone carboxylic acid derivatives such as pyromido acid, pipemidic acid and sinoxacin, and quaternary ammonium compounds such as benzalkonium cetyl phosphate These can be used alone or in combination of two or more.
- An example of a method for adding an antibacterial agent to the superabsorbent polymer is a method of attaching antibacterial fine particles described in JP-A No. 2016-104119 to the superabsorbent polymer.
- the superabsorbent polymer contained in the absorbent core 40 contains an antibacterial agent
- the covering sheet 44 that covers the absorbent core 40 contains a fragrance.
- the fragrance is arranged outside the superabsorbent polymer that is the source of odor.
- the covering sheet 44 is composed of a single sheet as shown in FIG. 1 and covers the absorbent core 40 so that the left and right side edge regions of the single covering sheet 44 overlap each other to form an overlapping portion 44A. If it does, since a fragrance arises from the whole absorber 4, the suppression effect of the odor resulting from a fragrance
- flavor when the fragrance
- transmits can be made remarkable.
- flavor is contained in the back sheet 3 side of the coating sheet 44, The suppression effect of the smell of excrement from the back sheet 3 side can also be made remarkable.
- the covering sheet 44 and the top sheet 2 are fixed with an adhesive such as a hot melt adhesive
- the covering sheet 44 and the back sheet 3 are adhesive such as a hot melt adhesive. It is fixed with.
- the adhesive such as a hot melt pressure-sensitive adhesive
- the cover sheet 44 is in direct contact with the top sheet 2 and the back sheet 3. Is blocked.
- the fragrance contained in the covering sheet 44 is effectively prevented from unintentionally shifting to the top sheet 2 and the back sheet 3.
- the effect of suppressing the odor due to the fragrance contained in the covering sheet 44 becomes even more remarkable.
- the absorbent core 40 and the covering sheet 44 are not joined by an adhesive such as a hot-melt pressure-sensitive adhesive, and both are in a non-joined state.
- flavor currently made is easy to transfer to the absorptive core 40.
- FIG. This also makes the effect of suppressing odor due to the fragrance contained in the covering sheet 44 even more remarkable.
- the space 46 exists between the side surface 40 ⁇ / b> S of the absorbent core 40 and the covering sheet 44, the perfume contained in the covering sheet 44 is absorbed by the space 46. It can be easily diffused over the entire length of the body 4. This also makes the effect of suppressing odor due to the fragrance contained in the covering sheet 44 even more remarkable. When this space 46 is maintained even when the absorbent article 1 is worn, the effect of suppressing odor by the fragrance becomes extremely remarkable.
- a fragrance used is diluted in an appropriate solvent (for example, water, ethanol, low molecular hydrocarbons, polyhydric alcohols, liquid LPG gas, dimethyl ether, etc.).
- an appropriate solvent for example, water, ethanol, low molecular hydrocarbons, polyhydric alcohols, liquid LPG gas, dimethyl ether, etc.
- a method of coating the coating sheet 44 by applying, spraying or impregnating the coating solution 44.
- the fragrance used in the present invention is not particularly limited as long as the fragrance can be evaporated into the atmosphere at atmospheric pressure, and a normal fragrance that can perceive the fragrance in an environment of normal temperature and pressure is used without particular limitation.
- a normal fragrance that can perceive the fragrance in an environment of normal temperature and pressure
- the same ones that have been conventionally used in the technical field can be used.
- a highly volatile fragrance component having a boiling point of about 250 ° C. or less, or a medium volatile fragrance component having a boiling point of about 250 to about 300 ° C. is preferably used.
- Examples of the highly volatile perfume ingredients include anisole, benzaldehyde, benzyl acetate, benzyl alcohol, benzyl formate, isobornyl acetate, citronellal, citronellol acetate, paracymene, decanal, dihydrolinalool, dihydromyrcenol, dimethylphenyl carbinol, Eucalyptol, 1-carvone, geranial, geraniol, geranyl acetate, geranyl nitrile, neryl acetate, nonyl acetate, linalool, ethyl linalool, linalyl acetate, phenylethyl alcohol, ⁇ -pinene, ⁇ -pinene, ⁇ -pinene, ⁇ - Examples include nonone, ⁇ -ionone, ⁇ -ionone, ⁇ -terpineol, ⁇ -terpineol, terpinyl
- moderately volatile perfume ingredients include amylcinnamaldehyde, methyl dihydrojasmonate, isoamyl salicylate, ⁇ -caryophyllene, cedrene, cedryl methyl ether, cinnamon alcohol, coumarin, dimethylbenzylcarbinyl acetate, isoeugenol, and ⁇ -methyl ionone. , Heliotropin, hexyl salicylate, cis-3-hexenyl salicylate, phenylhexanol, pentalide, and the like, and these can be used alone or in combination of two or more.
- a fragrance containing a fragrance having a rose, lavender, jasmine, or ylang-ylang fragrance Compositions can also be used.
- a fragrance composition include nerol, lavandulol, jasmar, and cyclopiden, and one of these can be used alone or two or more can be used in combination.
- the fragrance is a combination of a fragrance material composed of a plurality of fragrances (fragrance composition), such as the above-described fragrance composition alone, natural essential oil, or blended base. "Adjusted” is included.
- a fragrance composition containing a fragrance having a rose, lavender, jasmine, or ylang ylang-like fragrance can be used as the fragrance.
- the fragrance preferably contains a substance that inhibits activation of human olfactory receptors caused by urine odor components (hereinafter, this substance is also referred to as “antagonist fragrance”).
- the antagonist is a competitive antagonist that inhibits the action by competing for the binding site, and the antagonist fragrance is the target when the binding site is the olfactory receptor 20 as shown in FIG.
- the target odor molecule 21 is bound to the olfactory receptor 20 and the receptor 20 is activated to transmit odor information
- the target odor molecule 21 together with other molecules 22 is transmitted as shown in FIG.
- the other molecule 22 is used to inhibit the activation of the receptor for the target odor molecule 21 and consequently to suppress the odor recognized by the individual. .
- an antagonist fragrance it is possible to achieve odor suppression by olfactory receptor antagonism.
- the antagonist fragrance even if the fragrance of the antagonist fragrance itself is not strong, a high urine odor suppressing effect is exhibited.
- Smell suppression by olfactory receptor antagonism is different from the means of masking the target odor by the fragrance of the fragrance, even if it is a means of using other molecules as well Is done.
- An example of odor suppression by olfactory receptor antagonism is the case of using a substance that inhibits activation of the olfactory receptor, such as an antagonist. Applying a substance that inhibits activation to the receptor of the odor molecule that causes a specific odor inhibits the activation of the receptor to the odor molecule, and consequently suppresses the odor perceived by the individual. can do.
- p-cresol and 2-methoxy-4-vinylphenol are known as typical ones. It is preferable from the viewpoint of effective odor suppression to suppress the odor of these substances by olfactory receptor antagonism.
- p-Cresol and 2-methoxy-4-vinylphenol are representative of odor emitted from urine after urination or urine collection or urine that has been scattered and dried, or urine odor emitted from absorbent articles left after use It is a typical one.
- the “urine odor” is preferably an odor generated from urine that has passed through urination or after urine collection.
- the “urine odor” in the present specification may be a urine odor that is scattered and dried, or a urine odor emitted from an absorbent article that is left after use.
- the “urine odor” herein is the odor of urine treated with ⁇ -glucuronidase or an extract thereof.
- the antagonist fragrance is preferably any substance that inhibits the activation of OR9Q2, OR10G4, OR10G7, OR2W1, OR4S2, OR5P3, OR1A1, OR5K1 or OR8H1 as human olfactory receptors.
- OR9Q2, OR10G4, OR10G7, OR2W1, OR4S2, OR5P3, OR1A1, OR5K1 or OR8H1 as human olfactory receptors.
- particularly preferred antagonist flavors include the following compounds capable of binding to OR9Q2. These compounds can be used individually by 1 type or in combination of 2 or more types. ⁇ 3- (4-tert-butylphenyl) propanal (Bourgeonal) ⁇ 3,7,11-trimethyldodeca-1,6,10-trien-3-ol (Nerolidol) ⁇ Methylcedol ketone (1-[( 1S, 2R, 5R, 7S) -2,6,6,8-tetramethyltriclo [5.3.1.0 1,5 ] undec-8-en-9-yl] ethanol; Acetyledrene) 1- (2- tert-butylcyclohexyl) oxybutan-2-ol (Ambercore) 2,2,7,7-tetramethyltricyclo [6.2.1.0 1,6 ] undecan-5-one (iso-Longifolaneone) 2 -(2- (4-Methyl-3-cyclohexen-1-yl) propy
- the following compounds that can bind to OR2W1 are also preferably exemplified as the antagonist flavor.
- the fragrance is preferably an antagonist fragrance containing at least one selected from the above-mentioned compounds as an active ingredient.
- the content of the fragrance is not particularly limited, and can be appropriately set according to the desired deodorizing performance, absorption performance, and the like.
- flavor can be included per absorbent article.
- a relatively small content of about 0.1 mg or more and 50 mg or less is preferable in that a sufficient urine odor suppressing effect can be obtained.
- the absorbent article to which the present invention is applied widely includes various products used to absorb and retain human excreta. Examples include, but are not limited to, disposable diapers for baby and adults, incontinence pads for light incontinence, auxiliary pads used inside adult disposable diapers, sanitary napkins and panty liners. Absent.
- the absorptive core 40 is not restricted to the thing of this structure,
- the polymer non-existing region may be present only in the entire region, or the polymer non-existing region may be present only in the entire region of the non-skin facing surface of the absorbent core 40.
- the absorptive core 40 was coat
- a fragrance may be included in at least one coated sheet.
- the absorbent article 1 of the above embodiment can be manufactured by the following manufacturing method, for example.
- the absorptive core 1 which has a superabsorbent polymer containing an antibacterial agent is manufactured.
- the absorbent core 1 can be manufactured by various methods known in the art.
- a fragrance is included in the covering sheet 44.
- the absorptive core 1 is coat
- the absorbent article 1 can be manufactured by disposing the top sheet 2 on the skin facing surface side and the back sheet 3 on the non-skin facing surface side of the absorbent body 4 thus manufactured.
- the covering sheet 44 preferably includes a fragrance throughout the entire area.
- An absorbent article having a top sheet, a back sheet, and an absorbent body disposed between both sheets,
- the absorber includes an absorbent core and a covering sheet that covers the absorbent core,
- the absorbent core contains a superabsorbent polymer,
- the superabsorbent polymer contains an antibacterial agent,
- ⁇ 2> The absorbent article according to ⁇ 1>, wherein the absorbent core has a polymer non-existing region in which the superabsorbent polymer is absent on the surface thereof.
- One sheet of the covering sheet is used, and the covering sheet covers the absorbent core so that the left and right side edge areas thereof overlap each other to form an overlapping portion, and thereby the skin of the absorbent core faces the skin.
- ⁇ 4> The absorbent article according to ⁇ 3>, wherein the fragrance is included in the entire area of the covering sheet.
- ⁇ 5> The absorbent according to any one of ⁇ 1> to ⁇ 4>, wherein the absorbent body has a space defined by being separated from a side surface of the absorbent core and the covering sheet. Goods. ⁇ 6>
- the covering sheet covers the absorbent core so as to form an overlapping portion, The overlapping part of the said covering sheet is an absorbent article of any one of said ⁇ 1> thru
- the distance between the side surface of the absorbent core and the covering sheet is preferably 1 mm or more, more preferably 2 mm or more, and 3 mm or more. More preferably, it is preferably 10 mm or less, more preferably 7 mm or less, and even more preferably 5 mm or less.
- the absorptivity ⁇ 1> The distance between the side surface of the core and the covering sheet is preferably 1 mm or more and 10 mm or less, more preferably 2 mm or more and 7 mm or less, and further preferably 3 mm or more and 5 mm or less.
- the absorbent core has a relatively high basis weight and a high basis weight portion having a convex shape protruding toward the back sheet side; ⁇ 1> to ⁇ 8> that have a low basis weight portion that is adjacent to the high basis weight portion and has a relatively low basis weight and is recessed from the back sheet side toward the top sheet 2 side.
- ⁇ 10> The absorbent article according to ⁇ 9>, wherein the high basis weight portion and the low basis weight portion of the absorbent core are integrally formed.
- a plurality of the low basis weight portions extend in parallel with the longitudinal direction of the absorbent core, A plurality of the low basis weight parts, the plurality of which extend in parallel with the width direction of the absorbent core,
- ⁇ 12> The absorbent article according to any one of ⁇ 9> to ⁇ 11>, wherein a polymer non-existing region is provided on a tip surface of the high basis weight portion.
- ⁇ 13> The absorbent article according to any one of ⁇ 9> to ⁇ 12>, wherein a polymer non-existing region is provided on a convex side surface of the high basis weight portion and a front end surface of the low basis weight portion.
- ⁇ 14> The absorbent article according to any one of ⁇ 1> to ⁇ 13>, wherein the absorbent core has an uneven structure on a non-skin facing surface side.
- ⁇ 15> The absorbent article according to ⁇ 14>, wherein a polymer non-existing region exists in the entire surface of the concavo-convex structure on the non-skin facing surface side.
- ⁇ 16> The absorbent article according to ⁇ 12> or ⁇ 15>, wherein a thickness of the polymer non-existing region in the absorbent core is 0.1 mm or more and 1 mm or less inward from the surface.
- the said absorptive core has a block structure which consists of the said several high basic weight part with relatively high basic weight, and the said low basic weight part with comparatively low basic weight.
- the lower limit becomes like this. Preferably it is 20% or more, More preferably, it is 30% or more, Preferably an upper limit is 80% or less.
- the basis weight of the high basis weight part itself has a lower limit value of preferably 300 g / m 2 or more, more preferably 350 g / m 2 or more, and an upper limit value of preferably 900 g / m 2 or less. Preferably it is 800 g / m 2 or less,
- the basis weight of the low basis weight portion itself has a lower limit value of preferably 100 g / m 2 or more, more preferably 150 g / m 2 or more, and an upper limit value of preferably 500 g / m 2 or less.
- the lower limit of the thickness of the low basis weight relative to the thickness of the high basis weight is preferably 30% or more, more preferably 40% or more, and the upper limit is preferably 90% or less. Preferably it is 80% or less,
- the lower limit value of the thickness of the high basis weight part itself is preferably 2 mm or more, more preferably 3 mm or more, and the upper limit value is preferably 8 mm or less, more preferably 7 mm or less,
- the lower limit of the thickness of the low basis weight part itself is preferably 1.5 mm or more, more preferably 2.5 mm or more, and the upper limit is preferably 4.5 mm or less, more preferably 4 mm or less.
- ⁇ 17> or ⁇ 18> wherein ⁇ 20> In the non-skin facing surface of the absorbent core, a concavo-convex structure including a plurality of convex portions including the high basis weight portion and a concave portion including the low basis weight portion is formed.
- the end of the recess extending in the longitudinal direction of the absorbent core reaches the edge in the longitudinal direction of the absorbent core;
- the absorbent article according to any one of ⁇ 17> to ⁇ 19> wherein an end of a recess extending in the width direction of the absorbent core reaches a side edge in the width direction of the absorbent.
- ⁇ 21> The absorbent article according to any one of ⁇ 1> to ⁇ 20>, wherein the covering sheet and the top sheet are fixed with an adhesive.
- ⁇ 22> The absorbent article according to any one of ⁇ 1> to ⁇ 21>, wherein the covering sheet and the back sheet are fixed with an adhesive.
- ⁇ 23> The absorbent article according to any one of ⁇ 1> to ⁇ 22>, wherein the absorbent core and the covering sheet are not joined by an adhesive and are not joined.
- ⁇ 24> The absorbent article according to any one of ⁇ 1> to ⁇ 23>, wherein the fragrance contains a substance that inhibits activation of a human olfactory receptor due to a urine odor component.
- ⁇ 25> The absorbent article according to ⁇ 24>, wherein the perfume contains a substance that inhibits activation of a human olfactory receptor caused by p-cresol or 2-methoxy-4-vinylphenol.
- the olfactory receptor is any of OR9Q2, OR10G4, OR10G7, OR2W1, OR4S2, OR5P3, OR1A1, OR5K1, and OR8H1.
- the perfume is an effective ingredient selected from the group consisting of Bourgeonal, Nerolidol, Acetyledrene, Ambercore, iso-Longifoloneone, MethylCedylEther, Nectaryl, Thymol, Aldehyde C-12 MNA and Benzoin Siam.
- the absorbent article according to any one of ⁇ 24> to ⁇ 26>.
- Example 1 As an absorbent article, a light incontinence pad 50 cc size (Laurier Sara Pure Water Absorbing Napkin 50 cc) manufactured by Kao Corporation was used. The absorbent core of this absorbent article was removed, and the absorbent core having the structure shown in FIGS. 1 to 3 was disposed instead. This absorbent core was manufactured by the method described in JP2013-255567A. The absorbent core had a basis weight of 400 g / m 2 and had a polymer non-existing region on the surface on the non-skin facing surface side.
- piroctone olamine manufactured by Clariant, trade name “Octopirox”
- 1 part by mass of piroctone olamine was dissolved in 10 parts by mass of ethanol to prepare an antibacterial agent solution.
- This antibacterial agent solution was mixed with dry silica (manufactured by Nippon Aerosil Co., Ltd., trade name “Aerosil 200”, average primary particle size of 12 nm, average BET specific surface area of 200 m 2 / g) as silica fine particles as inorganic fine particles, and 10 mass of silica.
- the antibacterial fine particles in which the hydrophobic antibacterial agent is adhered to the surface of the silica fine particles were obtained by dripping and mixing the antibacterial agent solution to 10 parts by mass with respect to the parts, and drying the mixture at room temperature. . Then, water-absorbing polymer particles (trade name “AQUALIC CA” manufactured by Nippon Shokubai Co., Ltd., average particle diameter of 300 ⁇ m) and the antibacterial fine particles are mixed at a ratio of 1 part by mass with respect to 100 parts by mass of the former. Then, after obtaining a superabsorbent polymer containing an antibacterial agent, an absorbent core containing this superabsorbent polymer was obtained.
- the fragrances shown in Table 1 below were used. This fragrance was applied to the entire area of the tissue paper. This tissue paper was wound around the surface of the absorbent core in the manner shown in FIG. 1 to obtain an absorbent body.
- Example 3 In this comparative example, the absorptive core similar to Example 1 was used except not using the fragrance.
- Test Example 1 olfactory receptors that respond to urine odor components were identified.
- Test Example 1 1) Cloning of human olfactory receptor gene The human olfactory receptor was cloned by PCR using human genomic DNA female (G1521: Promega) as a template based on the sequence information registered in GenBank. Each gene amplified by the PCR method is incorporated into a pENTR vector (Invitrogen) according to the manual, and using the NotI and AscI sites existing on the pENTR vector, NotI prepared downstream of the Flag-Rho tag sequence on the pME18S vector, Recombined into the AscI site.
- pENTR vector Invitrogen
- HEK293 cells each expressing about 400 types of human olfactory receptors were prepared.
- a reaction solution having the composition shown in Table 2 was prepared and allowed to stand in a clean bench for 15 minutes, and then added to each well of a 96-well plate (BD).
- BD 96-well plate
- HEK293 cells (3 ⁇ 10 5 cells / cm 2 ) were seeded in 100 ⁇ L each well, and cultured for 24 hours in an incubator maintained at 37 ° C. and 5% CO 2 .
- Luciferase assay The olfactory receptor expressed in HEK293 cells increases the amount of intracellular cAMP by coupling with intracellular G ⁇ s and activating adenylate cyclase.
- a luciferase reporter gene assay was used which monitors the increase in intracellular cAMP level as a luminescence value derived from the firefly luciferase gene (fluc2P-CRE-hygro).
- a renilla luciferase gene fused with the CMV promoter downstream was simultaneously introduced, and used as an internal standard for correcting errors in gene transfer efficiency and cell number.
- the medium was removed, and 75 ⁇ L of a solution containing an odorous substance (p-cresol 1 mM or 2-methoxy-4-vinylphenol 300 ⁇ M) prepared with CD293 medium (Invitrogen) was added.
- the cells were cultured for 2.5 hours in a CO 2 incubator to fully express the luciferase gene in the cells.
- the luciferase activity was measured using a Dual-Glo TM luciferase assay system (Promega) according to the operation manual of the product.
- a value obtained by dividing the luminescence value derived from firefly luciferase induced by the odor substance stimulation by the luminescence value in the cells not subjected to the odor substance stimulation was calculated as a fold increase and used as an index of the response intensity.
- OR1A1, OR2W1, OR5K1, OR5P3, OR8H1, OR10G4 and OR10G7 showed responses (FIG. 7).
- the response of these olfactory receptors to 2-methoxy-4-vinylphenol was concentration dependent (FIG. 8).
- OR1A1, OR2W1, OR5K1, OR5P3, OR8H1, OR10G4 and OR10G7 are 2-methoxy-4-vinylphenol receptors that respond to 2-methoxy-4-vinylphenol.
- Test Example 2 1) Identification of urine odor receptor antagonist fragrance
- the antagonist fragrance of the olfactory receptor (urine odor receptor) that responds to the urine odor component identified in Test Example 1 was searched, and its urine odor suppression action was evaluated.
- p-cresol receptor OR9Q2 was used as an example of urine odor receptor.
- a test substance was applied to OR9Q2 expressed in HEK293 cells in the same procedure as in Test Example 1 under stimulation with 100 ⁇ M of p-cresol, and the inhibitory effect of the test substance on the p-cresol response of the receptor was examined. It was.
- the response intensity of OR9Q2 to p-cresol in the presence of the test substance was calculated as follows. For various stimulation conditions, a value fLuc / hRluc obtained by dividing the luminescence value derived from firefly luciferase by the luminescence value derived from Renilla luciferase was calculated. The fLuc / hRluc value (X) induced by odor stimulation with p-cresol alone was subtracted by the fLuc / hRluc value (Y) in cells that had not been stimulated by introduction of the same receptor, and p-cresol alone Receptor activity (XY) by stimulation was determined.
- the fLuc / hRluc value (Z) by stimulation with a mixture of p-cresol and a test substance is subtracted by the fLuc / hRluc value (Y) in cells without stimulation, and the receptor at the time of addition of the test substance Activity (ZY) was determined.
- the ratio of the receptor activity (ZY) at the time of addition of the test substance to the receptor activity (XY) by the stimulation with p-cresol alone was calculated by the following formula, and the response intensity of the receptor by the test substance (Response%) was determined. Independent experiments were performed three times, and the average value of each experiment was obtained.
- Response (%) (ZY) / (XY) ⁇ 100
- FIG. 9 shows the inhibitory effect of OR9Q2 on the p-cresol response by these substances. Nectaryl and Bourgeonal both suppressed the p9-cresol response of OR9Q2 at various concentrations.
- Nectaryl or Bourgeonal as the fragrance contained in the cover sheet of the absorbent article, it is possible to suppress the response of OR9Q2 due to the urine odor generated from the absorbent article, thereby effectively suppressing the urine odor. Can do.
- Urinary odor suppression ability by antagonist fragrance The urine odor suppression effect by the antagonist fragrances Bourgeonal and Nectaryl identified in 1) above was confirmed by a sensory test.
- a urine extract treated with ⁇ -glucuronidase was prepared as a urine odor component.
- Human urine stock solution was treated with ⁇ -glucuronidase at 37 ° C. for 2 hours, adjusted to about pH 4 with hydrochloric acid, and extracted with dichloromethane.
- a sodium hydroxide aqueous solution was added to the obtained dichloromethane phase, and the acidic component was transferred to the aqueous phase and extracted to remove the neutral component.
- the obtained aqueous phase was acidified with hydrochloric acid, re-extracted with diethyl ether, and concentrated to obtain an extract.
- An extract equivalent to 80 mL of the urine stock solution was dissolved in 1 mL of ethanol to obtain a urine extract.
- the urine extract diluted with mineral oil to 1.25% by volume was used as the urine odor component.
- Bourgeonal or Nectaryl was dissolved in mineral oil (Sigma) to prepare a 1% (v / v) solution, which was used as a test substance solution. Place two cotton balls in a 20 mL glass bottle (Marem, No.
- one cotton ball is impregnated with 30 ⁇ L of urine odor component, and the other cotton ball is one of the test substance solutions of either Bourgeonal or Nectaryl 30 ⁇ L was impregnated.
- the glass bottle containing the cotton ball was covered and allowed to stand at 37 ° C. for 1 hour, and then used as a odor sample in the sensory test. Only a urine odor component was prepared as a reference sample, and only mineral oil (Vehicle) was prepared as a control sample.
- the sensory test was conducted in a single blind manner by 10 evaluators. The test was started from 14:00 after 1 and a half hours had passed since the meal. In order to prevent the spread of odor, the test was basically performed near the draft. In order to eliminate the effect of adaptation to odor, the cognitive strength of urine odor from urine odor components was confirmed appropriately during the test, and a break was taken if necessary.
- the evaluators were divided into two groups. One group was evaluated from a odor sample containing Bourgeonal, and the other group was evaluated from a odor sample containing Nectaryl, and the urine odor suppression effect of the two test substances was evaluated. The odor sample was replaced with a new one after evaluation by three evaluators.
- the average value of the sensory test evaluation results by each evaluator is shown in FIG.
- an absorbent article that can effectively suppress odors such as urine odor caused by absorption of excrement is provided.
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Absorbent Articles And Supports Therefor (AREA)
Abstract
Un absorbeur (4) de cet article absorbant (1) comprend un noyau absorbant (40) et une feuille de recouvrement (44) qui recouvre le noyau absorbant (40). Le noyau absorbant 40 contient un polymère superabsorbant. Le polymère superabsorbant contient un agent antimicrobien. La feuille de recouvrement (44) contient un parfum. La surface du noyau absorbant (40) a de préférence une région exempte de polymère sans aucun polymère superabsorbant. Il est également préférable qu'une couche de feuille de recouvrement (44) soit utilisée pour recouvrir le noyau absorbant (40) de telle sorte que les régions de bord latéral gauche et droit de celle-ci se chevauchent mutuellement pour former une partie de chevauchement, recouvrant ainsi la surface faisant face à la peau, la surface non tournée vers la peau, et les deux surfaces latérales du noyau absorbant (40) avec la feuille de recouvrement (44).
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201780074998.1A CN110035721A (zh) | 2016-12-27 | 2017-11-30 | 吸收性物品 |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2016252362 | 2016-12-27 | ||
JP2016-252362 | 2016-12-27 | ||
JP2017-222122 | 2017-11-17 | ||
JP2017222122A JP6473492B2 (ja) | 2016-12-27 | 2017-11-17 | 吸収性物品 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2018123434A1 true WO2018123434A1 (fr) | 2018-07-05 |
Family
ID=62707341
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2017/043178 WO2018123434A1 (fr) | 2016-12-27 | 2017-11-30 | Article absorbant |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2018123434A1 (fr) |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH08246395A (ja) * | 1994-12-28 | 1996-09-24 | Inogami Kk | 吸収性シート及びその製造方法 |
JP2000513408A (ja) * | 1998-01-28 | 2000-10-10 | ザ、プロクター、エンド、ギャンブル、カンパニー | 抗菌性ヒドロゲル形成吸収ポリマーおよびその製造方法 |
JP2006297077A (ja) * | 2005-03-24 | 2006-11-02 | Kao Corp | 吸収性物品 |
JP2014166208A (ja) * | 2013-02-28 | 2014-09-11 | Daio Paper Corp | 吸収性物品 |
JP2015066373A (ja) * | 2013-09-30 | 2015-04-13 | ユニ・チャーム株式会社 | 吸収性物品 |
JP2015211667A (ja) * | 2014-04-14 | 2015-11-26 | 花王株式会社 | 尿臭抑制剤の探索方法 |
JP2016067749A (ja) * | 2014-09-30 | 2016-05-09 | ユニ・チャーム株式会社 | 吸収性物品 |
JP2016086872A (ja) * | 2014-10-30 | 2016-05-23 | 花王株式会社 | 吸収性物品 |
-
2017
- 2017-11-30 WO PCT/JP2017/043178 patent/WO2018123434A1/fr active Application Filing
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH08246395A (ja) * | 1994-12-28 | 1996-09-24 | Inogami Kk | 吸収性シート及びその製造方法 |
JP2000513408A (ja) * | 1998-01-28 | 2000-10-10 | ザ、プロクター、エンド、ギャンブル、カンパニー | 抗菌性ヒドロゲル形成吸収ポリマーおよびその製造方法 |
JP2006297077A (ja) * | 2005-03-24 | 2006-11-02 | Kao Corp | 吸収性物品 |
JP2014166208A (ja) * | 2013-02-28 | 2014-09-11 | Daio Paper Corp | 吸収性物品 |
JP2015066373A (ja) * | 2013-09-30 | 2015-04-13 | ユニ・チャーム株式会社 | 吸収性物品 |
JP2015211667A (ja) * | 2014-04-14 | 2015-11-26 | 花王株式会社 | 尿臭抑制剤の探索方法 |
JP2016067749A (ja) * | 2014-09-30 | 2016-05-09 | ユニ・チャーム株式会社 | 吸収性物品 |
JP2016086872A (ja) * | 2014-10-30 | 2016-05-23 | 花王株式会社 | 吸収性物品 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103917205B (zh) | 用于活性成分的触发释放和湿度的视觉指示的水性介质敏感性涂层组合物 | |
JP6627036B2 (ja) | 糞便臭抑制用フレグランス、それを用いたマイクロカプセル化フレグランス、糞便臭抑制機能付き繊維製品、糞便臭抑制用ペレット、マイクロカプセル化フレグランス噴霧スプレー及び糞便臭抑制用スプレー | |
US7473817B1 (en) | Absorbent article | |
JP5368829B2 (ja) | 吸収性物品 | |
CN107683126A (zh) | 具有槽和润湿指示标记的吸收制品 | |
US11517484B2 (en) | Absorbent article | |
JP6478495B2 (ja) | 吸収性物品 | |
JP7007801B2 (ja) | パンツ型着用物品 | |
RU2714308C2 (ru) | Дезодорирующее изделие | |
JP2009250642A (ja) | ウェットインジケーター組成物 | |
JP6473492B2 (ja) | 吸収性物品 | |
JP6186136B2 (ja) | 吸収性物品 | |
TWI823861B (zh) | 吸收性物品 | |
JP6262510B2 (ja) | 吸収性物品 | |
WO2018123434A1 (fr) | Article absorbant | |
JP2018166937A (ja) | 吸収性物品用シート及び吸収性物品 | |
JP6836389B2 (ja) | 吸収性物品 | |
JP6831674B2 (ja) | 尿臭抑制剤 | |
JP7285136B2 (ja) | 吸収性物品 | |
JP2019170734A (ja) | 吸収性物品 | |
JP2018102614A (ja) | 吸収性物品 | |
JP6920059B2 (ja) | 吸収性物品 | |
JP2018102613A (ja) | 吸収性物品 | |
JP3242253U (ja) | 吸収性物品 | |
JPWO2020008610A1 (ja) | 吸収性物品 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 17888361 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 17888361 Country of ref document: EP Kind code of ref document: A1 |